ponstan mefenamic acid 250mg capsule blister pack
pfizer australia pty ltd - mefenamic acid, quantity: 250 mg - capsule, hard - excipient ingredients: gelatin; carbon black; iron oxide yellow; brilliant blue fcf; lactose monohydrate; titanium dioxide - treatment of primary dysmenorrhoea and primary menorrhoea. short-term relief of mild to moderate pain such as dental pain and soft tissue pain.
ponstan 250 mg capsules
chemidex pharma limited - mefenamic acid - capsule, hard - 250 milligram(s) - fenamates; mefenamic acid
ponstan 250 mg capsules
chemidex pharma limited - mefenamic acid - capsule, hard - 250 milligram(s) - fenamates; mefenamic acid
ponstan 250mg capsules
chemidex pharma ltd - mefenamic acid - oral capsule - 250mg
ponstan mefenamic acid 250mg capsule blister pack
pfizer australia pty ltd - mefenamic acid, quantity: 250 mg - capsule, hard - excipient ingredients: lactose monohydrate; gelatin; titanium dioxide; brilliant blue fcf; iron oxide yellow; carbon black - treatment of primary dysmenorrhoea and primary menorrhagia. short term relief of mild to moderate pain such as dental pain and soft tissue pain.
mefenamic acid 250mg capsules
kent pharma (uk) ltd - mefenamic acid - oral capsule - 250mg
ponstan capsule
pfizer laboratories limited 197 lenana road - nairobi - mefenamic acid - capsule - 250mg - non-steroidal
ponstan 50 capsules
pfizer australia pty ltd - mefenamic acid -
ponstan
pfizer new zealand limited - mefenamic acid 250mg; - capsule - 250 mg - active: mefenamic acid 250mg excipient: gelatin - ponstan is indicated for the treatment of primary dysmenorrhoea, dysfunctional uterine bleeding and pain or menorrhagia due to iucds.
beta-prograne 160mg prolonged-release capsules
ltt pharma limited - propranolol hydrochloride - prolonged-release capsule - 160 milligram(s) - beta blocking agents, non-selective; propranolol